Literature DB >> 30855325

Incidence and Risk Factors for Cannula-Related Venous Thrombosis After Venovenous Extracorporeal Membrane Oxygenation in Adult Patients With Acute Respiratory Failure.

Christoph Fisser1, Christoph Reichenbächer1, Thomas Müller1, Roland Schneckenpointner1, Maximilian V Malfertheiner1, Alois Philipp2, Maik Foltan2, Dirk Lunz3, Florian Zeman4, Matthias Lubnow1.   

Abstract

OBJECTIVES: Venovenous extracorporeal membrane oxygenation is indicated in patients with severe refractory acute respiratory failure. Venous thrombosis due to indwelling catheters is a frequent complication. The aim of this study was to analyze the incidence of cannula-related thrombosis and its risk factors after venovenous extracorporeal membrane oxygenation.
DESIGN: Retrospective observational study.
SETTING: A medical ICU at the University Hospital Regensburg. PATIENTS: We analyzed consecutive patients with severe respiratory failure (PaO2/FIO2 < 85 mm Hg and/or respiratory acidosis with pH < 7.25) who were successfully treated with venovenous extracorporeal membrane oxygenation in a medical ICU between 2010 and 2017. INTERVENTION: None.
MEASUREMENTS AND MAIN RESULTS: After extracorporeal membrane oxygenation weaning, duplex sonography or CT was conducted to detect cannula-related thrombosis. Thrombosis was classified as a large thrombosis by vein occlusion of greater than 50%. The incidence of thrombosis was correlated with risk factors such as coagulation variables (mean activated partial thromboplastin time ≤ 50 s, international normalized ratio antithrombin III, fibrinogen, plasma-free hemoglobin, platelets, and decline in D-dimer ≤ 50% the day after decannulation), cannula size, time on venovenous extracorporeal membrane oxygenation, renal failure, and underlying malignant disease. Data cut-off points were identified by receiver operating characteristic analysis. One-hundred seventy-two of 197 patients (87%) were screened. One-hundred six patients (62%) showed thrombosis that was considered large in 48 of 172 (28%). The incidence of thrombosis was higher in patients with a mean aPTT of less than or equal to 50 seconds (odds ratio, 1.02; p = 0.013) and in patients with a decline in D-dimer less than or equal to 50% (odds ratio, 2.76; p = 0.041) the day after decannulation following adjustment for risk factors.
CONCLUSIONS: The incidence of cannula-related venous thrombosis after venovenous extracorporeal membrane oxygenation is high. Reduced systemic anticoagulation may enhance the risk of thrombosis. Sustained elevation of D-dimer after decannulation may indicate thrombosis. Patients should undergo routine duplex sonography after extracorporeal membrane oxygenation to detect thrombosis formation in the cannulated vessel.

Entities:  

Mesh:

Year:  2019        PMID: 30855325     DOI: 10.1097/CCM.0000000000003650

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Why we need safer anticoagulant strategies for patients on short-term percutaneous mechanical circulatory support.

Authors:  Christophe Vandenbriele; Thomas Vanassche; Susanna Price
Journal:  Intensive Care Med       Date:  2020-01-23       Impact factor: 17.440

Review 2.  COVID-19 and Extracorporeal Membrane Oxygenation.

Authors:  Gennaro Martucci; Artur Słomka; Steven Eric Lebowitz; Giuseppe Maria Raffa; Pietro Giorgio Malvindi; Valeria Lo Coco; Justyna Swol; Ewa Żekanowska; Roberto Lorusso; Waldemar Wierzba; Piotr Suwalski; Mariusz Kowalewski
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review.

Authors:  Mariusz Kowalewski; Dario Fina; Artur Słomka; Giuseppe Maria Raffa; Gennaro Martucci; Valeria Lo Coco; Maria Elena De Piero; Marco Ranucci; Piotr Suwalski; Roberto Lorusso
Journal:  Crit Care       Date:  2020-05-08       Impact factor: 9.097

4.  Venous thromboembolism prophylaxis in the trauma intensive care unit: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document.

Authors:  Joseph F Rappold; Forest R Sheppard; Samuel P Carmichael Ii; Joseph Cuschieri; Eric Ley; Erika Rangel; Anupamaa J Seshadri; Christopher P Michetti
Journal:  Trauma Surg Acute Care Open       Date:  2021-02-24

5.  Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity-score matched study.

Authors:  Christoph Fisser; Maren Winkler; Maximilian V Malfertheiner; Alois Philipp; Maik Foltan; Dirk Lunz; Florian Zeman; Lars S Maier; Matthias Lubnow; Thomas Müller
Journal:  Crit Care       Date:  2021-04-29       Impact factor: 9.097

6.  Coagulation abnormalities in patients with COVID-19 on venovenous ECLS increased risk for technical complications and support times but had no impact on survival.

Authors:  Karla Lehle; Alois Philipp; Maik Foltan; Frank Schettler; Markus Ritzka; Thomas Müller; Matthias Lubnow
Journal:  Artif Organs       Date:  2022-03-03       Impact factor: 2.663

7.  Arterial and venous vascular complications in patients requiring peripheral venoarterial extracorporeal membrane oxygenation.

Authors:  Christoph Fisser; Corina Armbrüster; Clemens Wiest; Alois Philipp; Maik Foltan; Dirk Lunz; Karin Pfister; Roland Schneckenpointner; Christof Schmid; Lars S Maier; Thomas Müller; Matthias Lubnow
Journal:  Front Med (Lausanne)       Date:  2022-07-28

8.  Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19.

Authors:  Huseyin Arikan; Jeremy Cordingley
Journal:  Breathe (Sheff)       Date:  2021-03

9.  Femoral neuropathy following venoarterial-extracorporeal membrane oxygenation therapy: a case report.

Authors:  Albert Youngwoo Jang; Young Jun Oh; Seok In Lee; Oh Kyung Lim; Soon Yong Suh
Journal:  BMC Cardiovasc Disord       Date:  2020-08-27       Impact factor: 2.298

Review 10.  A rational approach on the use of extracorporeal membrane oxygenation in severe hypoxemia: advanced technology is not a panacea.

Authors:  Dimitris Georgopoulos; Laurent Brochard; Evangelia Akoumianaki; Annemijn Jonkman; Michael C Sklar
Journal:  Ann Intensive Care       Date:  2021-07-12       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.